CatalystWireBeta

Results of Meetings

In brief · summary, not quotable

KR1 plc announced that all resolutions were passed at its Annual and Extraordinary General Meetings, with strong support for the re-appointment of auditors and directors, and for adopting new articles and authorising share allotments for a placing programme and performance fees. Notably, resolutions concerning the adoption of new articles and authorising share allotments for the placing programme and performance fees received over 98.7% of votes in favour. The company also confirmed its ordinary shares are expected to be admitted to the London Stock Exchange's Main Market on November 25, 2025, with trading on the Aquis Growth Market ceasing on November 24, 2025.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your KR1 notes

KR1 plc (KR1:AQSE), a leading digital asset company, is pleased to announce that all Resolutions were duly passed at the Annual General Meeting and the Extraordinary General Meeting of the Company held earlier today.

The votes cast at the meetings are set out in the tables below.

Annual General Meeting

ResolutionForAgainstTotal votes cast as % of Issued Share CapitalVotes Withheld
Number of Votes% of shares votedNumber of Votes% of shares voted
1. To receive the 2024 report & accounts.53,598,20799.8%90,3920.2%30.2%174,225
2. To re-appoint PKF Littlejohn LLP as auditors.53,577,26998.3%94,3921.7%30.7%191,163
3. To re-elect Rhys Davies as a director.50,817,14594.7%2,841,5555.3%30.2%204,124
4. To re-elect Aeron Buchanan as a director.53,466,13999.6%192,5610.4%30.2%204,124
5. To re-elect Mona Elisa as a director.53,165,05199.1%493,6490.9%30.2%204,124
6. To re-elect George McDonaugh as a director.52,081,57097.0%1,589,1303.0%30.2%192,124
7. To re-elect Keld van Schreven as a director.52,081,57097.0%1,589,1303.0%30.2%192,124
Extraordinary General Meeting
ResolutionForAgainstTotal votes cast as % of Issued Share CapitalVotes Withheld
Number of Votes% of shares votedNumber of Votes% of shares voted
1. To adopt the New Articles.52,305,42899.7%165,2470.3%29.5%155,079
2. To authorise the allotment of ordinary shares in connection with the Placing Programme51,770,42698.7%666,5871.3%29.5%188,741
3. To authorise the allotment of ordinary shares in connection with any Performance Fees.51,798,21298.8%636,5471.2%29.5%190,995
4. To authorise the Company to make market acquisitions of ordinary shares.52,304,43599.7%164,6000.3%29.5%156,719

The 'for' votes include those giving discretion to the Chairman. A 'vote withheld' is not a vote in law and is not counted in the calculation of the votes 'for' or 'against' a resolution.

In accordance with the Company's announcement of 29 October 2025, application has been made to the FCA and the London Stock Exchange for the Company's ordinary shares to be admitted to the equity shares (commercial companies) category of the Official List and to trading on the Main Market of the London Stock Exchange. It is expected that admission will become effective and that dealings in the Company's ordinary shares will commence at 8.00 a.m. on 25 November 2025.

Accordingly, admission of the Company's ordinary shares to trading on the Apex segment of the Aquis Growth Market will be cancelled, with the last day of trading expected to be 24 November 2025.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note